Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Hum Exp Toxicol ; 39(11): 1518-1527, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32519556

ABSTRACT

Ethephon, a member of the organophosphorus compounds, is one of the most widely used plant growth regulators for artificial ripening. Although million pounds of this chemical is being used annually, the knowledge regarding its molecular toxicity is yet not sufficient. The purpose of this study was to evaluate the potential developmental toxicity of ethephon using embryonic stem cell model. The mouse embryonic stem cells (mESCs) were exposed to various concentrations of ethephon and the viability, cell cycle alteration and changes in the gene expression profile were evaluated using high-throughput RNA sequencing. Further, the effect of ethephon on neural differentiation potential was examined. The results showed that ethephon at noncytotoxic doses induced cell cycle arrest in mESCs. Gene ontology enrichment analysis showed that terms related to cell fate and organismal development, including neuron fate commitment, embryo development and cardiac cell differentiation, were markedly enriched in ethephon-treated cells. Neural induction of mESCs in the presence of ethephon was inhibited and the expression of neural genes was decreased in differentiated cells. Results obtained from this work clearly demonstrate that ethephon affects the gene expression profile of undifferentiated mESCs and prevents neural differentiation. Therefore, more caution against the frequent application of ethephon is advised.


Subject(s)
Mouse Embryonic Stem Cells/drug effects , Organophosphorus Compounds/toxicity , Plant Growth Regulators/toxicity , Transcriptome/drug effects , Animals , Cell Cycle/drug effects , Cell Survival/drug effects , Cells, Cultured , Mice , Mouse Embryonic Stem Cells/metabolism , Neurogenesis/drug effects
2.
Hum Exp Toxicol ; 37(2): 107-117, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29233028

ABSTRACT

BACKGROUND: In aluminum phosphide (AlP) poisoning, death is mainly due to cardiovascular failure and refractory acute heart failure. There is a lot of evidence showing thyroid hormones have cardioprotective effects. OBJECTIVE: The purpose of this study was to evaluate the effect of oral liothyronine in the treatment of AlP poisoning. METHODS: Twenty-four patients from intensive care unit of Baharloo Hospital, Tehran, Iran, were included based on the inclusion and exclusion criteria. They were randomly divided into two parallel groups of 12 cases and 12 controls. Intervention in the case group was administration of 50 µg liothyronine via nasogastric tube after gastric lavage, in the first 6 h of poisoning. In both groups, the routine treatment of AlP poisoning was performed. Blood samples were prepared at the beginning of the study and after 12 h. Patients were followed up till discharge from the hospital or death. RESULTS: The findings demonstrated that oral liothyronine was able to significantly improve systolic blood pressure, arterial blood pH, and total thiol molecules and also could decrease lipid peroxidation, increase catalase activity, and prevent further decline in total antioxidant capacity. CONCLUSION: Liothyronine administration is effective in controlling AlP poisoning and can improve patients' outcome.


Subject(s)
Aluminum Compounds/poisoning , Antidotes/administration & dosage , Cardiovascular Diseases/drug therapy , Pesticides/poisoning , Phosphines/poisoning , Triiodothyronine/administration & dosage , Administration, Oral , Adult , Antidotes/adverse effects , Biomarkers/blood , Blood Pressure/drug effects , Cardiovascular Diseases/chemically induced , Cardiovascular Diseases/mortality , Cardiovascular Diseases/physiopathology , Female , Humans , Hydrogen-Ion Concentration , Iran , Lipid Peroxidation/drug effects , Male , Oxidative Stress/drug effects , Time Factors , Treatment Outcome , Triiodothyronine/adverse effects
3.
Hum Exp Toxicol ; 32(5): 544-53, 2013 May.
Article in English | MEDLINE | ID: mdl-23696423

ABSTRACT

Type I diabetes mellitus is a metabolic disease caused by the impairment of pancreatic ß-cells mainly mediated through oxidative stress and related apoptosis. Islets transplantation seems a promising treatment for these patients, but during islets transplant, various types of stresses related to the isolation and transplantation procedure compromise the function and viability of islets. We recently hypothesized that the combination of cerium oxide (CeO2) and yttrium oxide (Y2O3) nanoparticles with a potential free radical scavenger behavior should be useful to make isolated islets survive until transplanted. In the present study, oxidative stress-induced apoptosis in isolated rat pancreatic islets exposed to hydrogen peroxide (H2O2) and the protective effects of CeO2 and Y2O3 nanoparticles were investigated. Exposure of islets to H2O2 (50 µm, 2 h) increased intracellular oxidant formation such as reactive oxygen species and subsequently apoptosis and decreased viability, glucose-induced adenosine triphosphate (ATP) production and glucose-stimulated insulin secretion. Pretreatment with CeO2 and/or Y2O3 nanoparticles reduced the oxidant formation and apoptosis and increased viability, glucose-induced ATP production and glucose-stimulated insulin secretion. These results suggest that this combination may protect ß-cell apoptosis by improving the oxidative stress-mediated apoptotic pathway.


Subject(s)
Apoptosis/drug effects , Cerium/pharmacology , Islets of Langerhans/drug effects , Yttrium/pharmacology , Adenosine Triphosphate/biosynthesis , Animals , Caspase 3/metabolism , Caspase 9/metabolism , Insulin/metabolism , Insulin Secretion , Islets of Langerhans/pathology , Male , Metal Nanoparticles , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...